Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Sep 10, 2021

Accession no.
0001209191-21-055500
Filed
Sep 10, 2021
Trade date
May 28-Jun 30, 2021
Filing delay
105 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 23 non-derivative transactions. Open-market purchases total $1.05K. It was filed 105 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 28, 2021Common StockPPurchaseAcquired+15$2.93+$43.955,768,184Direct
Jun 1, 2021Common StockPPurchaseAcquired+15$2.94+$44.15,768,199Direct
Jun 2, 2021Common StockPPurchaseAcquired+15$2.89+$43.355,768,214Direct
Jun 3, 2021Common StockPPurchaseAcquired+15$2.81+$42.155,768,229Direct
Jun 4, 2021Common StockPPurchaseAcquired+15$2.93+$43.955,768,244Direct
Jun 7, 2021Common StockPPurchaseAcquired+15$2.94+$44.15,768,259Direct
Jun 8, 2021Common StockPPurchaseAcquired+15$2.99+$44.855,768,274Direct
Jun 9, 2021Common StockPPurchaseAcquired+15$3.14+$47.15,768,289Direct
Jun 10, 2021Common StockPPurchaseAcquired+15$3.25+$48.755,768,304Direct
Jun 11, 2021Common StockPPurchaseAcquired+15$3.18+$47.75,768,319Direct
Jun 14, 2021Common StockPPurchaseAcquired+15$3.09+$46.355,768,334Direct
Jun 15, 2021Common StockPPurchaseAcquired+15$3.09+$46.355,768,349Direct
Jun 16, 2021Common StockPPurchaseAcquired+15$3.09+$46.355,768,364Direct
Jun 17, 2021Common StockPPurchaseAcquired+15$3.08+$46.25,768,379Direct
Jun 18, 2021Common StockPPurchaseAcquired+15$2.99+$44.855,768,394Direct
Jun 21, 2021Common StockPPurchaseAcquired+15$3.14+$47.15,768,409Direct
Jun 22, 2021Common StockPPurchaseAcquired+15$3.05+$45.755,768,424Direct
Jun 23, 2021Common StockPPurchaseAcquired+15$3.07+$46.055,768,439Direct
Jun 24, 2021Common StockPPurchaseAcquired+15$3.09+$46.355,768,454Direct
Jun 25, 2021Common StockPPurchaseAcquired+15$3.09+$46.355,768,469Direct
Jun 28, 2021Common StockPPurchaseAcquired+15$3.16+$47.45,768,484Direct
Jun 29, 2021Common StockPPurchaseAcquired+15$3.03+$45.455,768,499Direct
Jun 30, 2021Common StockPPurchaseAcquired+15$2.93+$43.955,768,514Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)